mRNA technologies paint an optimistic future in cancer treatment.
kidney cancer
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Welireg: New Treatment for Tumors in Von Hippel–Lindau Disease
Belzutifan by Merck & Co. is for the treatment of renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors.